FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models.
Clin Cancer Res
; 26(15): 4154-4167, 2020 08 01.
Article
in En
| MEDLINE
| ID: mdl-32345647
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antibodies, Bispecific
/
Tumor Necrosis Factor Receptor Superfamily, Member 9
/
B7-H1 Antigen
/
Antineoplastic Agents, Immunological
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States